Grant: CIHR Clinician Scientist - Phase 1
Direct Payment
$125,000.00
The role of bone marrow-derived stem cells (BMDCs) in the development of and progression to gastric cancer.
FY 2008-09
Summary
Stomach cancer, medically termed gastric cancer, is a malignancy strongly linked to H. pylori (a gram-negative bacteria infecting over half of the world's population). Gastric cancer is a prototype for an "inflammation-linked cancer". While gastric cancer has been declining in North America, it remains the second most common cause of cancer-related mortality in the world.
The Helicobacter-dependent mouse model of gastric cancer mimics in most respects the histopathologic sequence well described in humans.
Dr. Wang has recently shown that gastric cancer originates not from gastric derived epithelial cells, but rather from circulating bone marrow derived stem cells (BMDCs). In this study I will test the hypothesis that increased levels of circulating BMDCs expressing K19, a cytoskeletal protein, is a risk factor for the development of gastric cancer.
We will determine whether levels of circulating K19 positive BMDCs are elevated in the setting of gastric cancer, and whether these cells accelerate the progression of gastric cancer in the mouse model. These studies will help characterize more specfically what type of stem cell is the origin of gastric cancer. We hope that our findings could potentially lead us on to clinical studies using the level of stem cells as a marker of cancer risk and to provide a therapeutic target for the treatment of gastric cancer.
Department
Program
CIHR Clinician Scientist - Phase 1
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
173685
Name
Asfaha Samuel
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
The role of bone marrow-derived stem cells (BMDCs) in the development of and progression to gastric cancer.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$125,000
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Gastric Cancer; Helicobacter Pylori; Inflammation; Stem Cells
Abstract
Stomach cancer, medically termed gastric cancer, is a malignancy strongly linked to H. pylori (a gram-negative bacteria infecting over half of the world's population). Gastric cancer is a prototype for an "inflammation-linked cancer". While gastric cancer has been declining in North America, it remains the second most common cause of cancer-related mortality in the world.
The Helicobacter-dependent mouse model of gastric cancer mimics in most respects the histopathologic sequence well described in humans.
Dr. Wang has recently shown that gastric cancer originates not from gastric derived epithelial cells, but rather from circulating bone marrow derived stem cells (BMDCs). In this study I will test the hypothesis that increased levels of circulating BMDCs expressing K19, a cytoskeletal protein, is a risk factor for the development of gastric cancer.
We will determine whether levels of circulating K19 positive BMDCs are elevated in the setting of gastric cancer, and whether these cells accelerate the progression of gastric cancer in the mouse model. These studies will help characterize more specfically what type of stem cell is the origin of gastric cancer. We hope that our findings could potentially lead us on to clinical studies using the level of stem cells as a marker of cancer risk and to provide a therapeutic target for the treatment of gastric cancer.
Competitiondate
200809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Asfaha, Samuel
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $125,000~ $0~